TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS OF AN OPEN-LABEL, LONG-TERM EXTENSION STUDY WITH UP TO 4.9 YEARS OF TREATMENT

Gary R. Lichtenstein  1     Edward V. Loftus Jr.  2     Stuart Bloom  3     Nervin Lawendy  4     Gary Chan  5     Gary S. Friedman     Haiying Zhang     Wenjin Wang     Andrew J. Thorpe     Chudy I. Nduaka     Chinyu Su    
1 Division of Gastroenterology, University of Pennsylvania School of Medicine,Philadelphia, PA,United States
2 Division of Gastroenterology and Hepatology, Mayo Clinic,Rochester, MN,United States
3 University College London Hospitals NHS Foundation Trust,London,United Kingdom
4 Pfizer Inc,Collegeville, PA,United States
5 Pfizer Inc,Collegevi

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing